世界の安定同位体標識化合物市場予測2024年：種類別、用途別、エンドユーザー別、地域別

LINEで送る

1 Introduction (Page No. – 16)
1.1 Objectives of the Study
1.2 Market Definition
1.2.1 Market Scope
1.2.2 Markets Covered
1.2.3 Years Considered for the Study
1.3 Currency
1.4 Limitations
1.5 Stakeholders
2 Research Methodology (Page No. – 20)
2.1 Research Data
2.2 Secondary Data
2.2.1 Key Data From Secondary Sources
2.3 Primary Data
2.3.1 Key Data From Primary Sources
2.4 Market Size Estimation
2.4.1 Revenue Mapping-Based Market Estimation
2.5 Data Triangulation
2.5.1 Assumptions for the Study
2.5.2 Limitations
3 Executive Summary (Page No. – 29)
4 Premium Insights (Page No. – 32)
4.1 Stable Isotope-Labeled Compounds Market Overview
4.2 North America: Stable Isotope-Labeled Compounds Market, By Application (2018)
4.3 Geographical Snapshot of the Stable Isotope-Labeled Compounds Market
5 Market Overview (Page No. – 35)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increase in Research Activities in the Pharmaceutical & Biotechnology Sectors
5.2.1.2 Growing Proteomics Research
5.2.1.3 Growing Prevalence of Cancer
5.2.2 Restraints
5.2.2.1 High Cost of Stable Isotope-Labeled Compounds
5.2.3 Opportunities
5.2.3.1 Growing Investments in Pharmaceutical R&D in Emerging Markets
5.2.4 Challenges
5.2.4.1 Dearth of Skilled Professionals
6 Stable Isotope-Labeled Compounds Market, By Type (Page No. – 40)
6.1 Introduction
6.2 Hydrogen-2
6.2.1 Growing Applications of H-2 in Pharmaceutical Research Will Drive the Demand for Labeled Compounds
6.3 Carbon-13
6.3.1 Growing Number of Metabolomics Studies and Applications in Disease Diagnosis are Driving Market Growth
6.4 Oxygen-18
6.4.1 Increasing Research on Cancer is Expected to Drive the Demand for Oxygen-18-Labeled Isotopes
6.5 Nitrogen-15
6.5.1 Expanding Applications of N-15 in Agricultural Investigation and Rising Research are Likely to Drive Market Demand
6.6 Other Stable Isotopes
7 Stable Isotope-Labeled Compounds Market, By Application (Page No. – 51)
7.1 Introduction
7.2 Research Applications
7.2.1 Biomedical Research
7.2.1.1 Increasing Number of Biomedical Research Activities Involving Stable Isotopes to Drive the Stable Isotope-Labeled Compounds Market for Biomedical Research
7.2.2 Pharmaceutical Research
7.2.2.1 Stable Isotopically Modified Pharmaceutical Agents Offer Reduced Side-Effects, Improved Oral Bioavailability, and Increased Half-Life—Key Factors Driving Market Growth
7.2.3 Environmental & Ecological Research
7.2.3.1 Increasing Use of Stable to Study the Feeding Ecology of Living Or Extinct Animal Species Through the Analysis of Their Ratios in Carcasses Or Remains to Drive Market Growth
7.2.4 Agricultural Research
7.2.4.1 Increasing Use of Stable Isotopes to Prevent Soil Pollution and Contamination and Facilitate Maximum Crop Production to Drive Growth in This Market
7.3 Clinical Diagnostics
7.3.1 Increasing Adoption of Pet Scans and Gamma Imaging for Disease Staging to Support Market Growth
7.4 Industrial Applications
7.4.1 Growing Application of Stable Isotopes in the Nuclear Industry and the Increasing Number of Nuclear Reactors to Support Market Growth
7.5 Other Applications
8 Stable Isotope-Labeled Compounds Market, By End User (Page No. – 63)
8.1 Introduction
8.2 Pharmaceutical & Biotechnology Companies
8.2.1 Increase in R&D Activities to Drive the Demand for Stable Isotope-Labeled Compounds Among Pharma & Biotech Companies
8.3 Academic & Research Institutes
8.3.1 Growing Research on Various Treatment Therapies is Driving the Growth of This End-User Segment
8.4 Hospitals & Diagnostic Centers
8.4.1 Adoption of Stable Isotopes has Increased Owing to the Rising Prevalence of Target Diseases
8.5 Other End Users
9 Stable Isotope-Labeled Compounds Market, By Region (Page No. – 73)
9.1 Introduction
9.2 North America
9.2.1 US
9.2.1.1 The US Dominates the North American Stable Isotope-Labeled Compounds Market
9.2.2 Canada
9.2.2.1 Availability of Funding Will Drive the Market in Canada
9.3 Europe
9.3.1 Germany
9.3.1.1 Germany is the Fastest-Growing Market in Europe
9.3.2 UK
9.3.2.1 Favorable Scenario for Environmental Research and Increasing Prevalence of Cancer are Key Growth Drivers in the UK
9.3.3 France
9.3.3.1 France has A Large and Well-Developed Biotech Industry
9.3.4 Italy
9.3.4.1 Strong Government Support for Research has Stimulated Market Growth in Italy
9.3.5 Spain
9.3.5.1 Increasing Research Activities and Expenditure Shows Significant Market Growth Potential in Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.1.1 China Dominates the Stable Isotope-Labeled Compounds Market in the APAC
9.4.2 Japan
9.4.2.1 Growing Support and Funding have Raised Research Intensity in Japan
9.4.3 India
9.4.3.1 Government Initiatives have Strengthened the Life Science Industry in India
9.4.4 Australia
9.4.4.1 Growing Funding for Research and Collaborations have Supported Market Growth in Australia
9.4.5 Rest of Asia Pacific
9.5 Rest of the World
10 Competitive Landscape (Page No. – 110)
10.1 Overview
10.2 Market Share Analysis, 2018
10.3 Competitive Scenario
10.4 Competitive Leadership Mapping (2018)
10.4.1 Visionary Leaders
10.4.2 Innovators
10.4.3 Dynamic Differentiators
10.4.4 Emerging Companies
11 Company Profiles (Page No. – 114)
(Business Overview, Products Offered, Recent Developments, Competitive Analysis, MnM View)*
11.1 Cambridge Isotope Laboratories
11.2 Merck KGaA
11.3 URENCO Limited
11.4 Isosciences
11.5 Medical Isotopes
11.6 Omicron Biochemicals
11.7 Trace Sciences International
11.8 Alsachim
11.9 Taiyo Nippon Sanso Corporation
11.10 PerkinElmer
11.11 Rotem Industries Israel
11.12 BOC Sciences
11.13 CortecNet
11.14 ISOFLEX
11.15 Huayi Isotopes Co.
11.16 Mesbah Energy Co.
11.17 Shanghai Research Institute of Chemical Industry
11.18 13c Molecular
11.19 C/D/N Isotopes
11.20 Shoko Co.
*Business Overview, Products Offered, Recent Developments, Competitive Analysis, MnM View Might Not Be Captured in Case of Unlisted Companies.
12 Appendix (Page No. – 138)
12.1 Discussion Guide
12.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
12.3 Available Customizations
12.4 Related Reports
12.5 Author Details

【関連データ：市場動向/規模/将来展望等のグローバル分析データ】

  1. 北米の核医学/放射性医薬品市場予測2024年：種類別、用途別
※当サイトのレポート紹介カバレッジ
■産業：医療、IT、電子、自動車、産業機械、建設、消費財、食品、化学、材料、エネルギー、金融、サービスなど多様
■地域：世界市場、アジア市場、中国市場、欧州市場、北米市場、中南米市場、中東市場、アフリカ市場など全世界
■レポート種類：市場動向、規模、占有率、トレンド、将来展望、未来予測、業界分析、産業分析、企業分析、事業機会分析、戦略提言など多様